Waterloo, Canada

Dafeng Chu

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal2 out of 237 
 
Positec Power Tools (Suzhou) Co., Ltd.
 patents
silverMedal2 out of 832,912 
Other
 patents
where one patent can have more than one assignee

Years Active: 2018-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dafeng Chu: Innovator in Gene Therapy

Introduction

Dafeng Chu is a notable inventor based in Waterloo, Canada. He has made significant contributions to the field of gene therapy through his innovative work on peptide-siRNA complexes. His research focuses on enhancing the delivery and efficacy of siRNA molecules in cellular applications.

Latest Patents

Dafeng Chu holds 2 patents related to his groundbreaking work. His latest patents include a series of peptides and a peptide-siRNA complex that effectively enhances the delivery of siRNA molecules into cells. This complex not only improves the release of siRNA within the cell but also enhances the efficiency of siRNA-mediated gene silencing of cellular targets. Additionally, pharmaceutical compositions that incorporate this complex and its applications in gene therapy are also disclosed in his patents.

Career Highlights

Throughout his career, Dafeng Chu has worked with various companies, including Positec Power Tools (Suzhou) Co., Ltd. His experience in the industry has allowed him to apply his innovative ideas in practical settings, contributing to advancements in biotechnology.

Collaborations

Dafeng has collaborated with notable individuals in his field, including coworkers Pu Chen and Baoling Chen. These collaborations have further enriched his research and development efforts.

Conclusion

Dafeng Chu's contributions to gene therapy through his innovative patents and collaborations highlight his role as a significant inventor in the biotechnology sector. His work continues to pave the way for advancements in the delivery and efficacy of therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…